I Gilaberte

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. doi Different levels of lack of improvement at 4 weeks of escitalopram treatment as predictors of poor 8-week outcome in MDD
    I Gilaberte
    Eli Lilly and Company, Madrid, Spain
    J Affect Disord 146:433-7. 2013
  2. pmc Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    McLean Hospital, Belmont, MA, USA
    BMC Psychiatry 7:43. 2007
  3. ncbi Fluoxetine in the prevention of depressive recurrences: a double-blind study
    I Gilaberte
    Lilly Research Centre, Windlesham, Surrey, United Kingdom
    J Clin Psychopharmacol 21:417-24. 2001
  4. ncbi Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial
    J A Sacristan
    Clinical Research Department, Lilly SA, Madrid, Spain
    Int Clin Psychopharmacol 15:107-13. 2000
  5. ncbi Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study
    A Montoya
    Laboratorios Lilly, Spain
    Actas Esp Psiquiatr 35:315-22. 2007

Collaborators

Detail Information

Publications5

  1. doi Different levels of lack of improvement at 4 weeks of escitalopram treatment as predictors of poor 8-week outcome in MDD
    I Gilaberte
    Eli Lilly and Company, Madrid, Spain
    J Affect Disord 146:433-7. 2013
    ..This post-hoc analysis evaluates different cut-off points of non-improvement at 4 weeks of escitalopram treatment to predict 8-week non-response and non-remission...
  2. pmc Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    McLean Hospital, Belmont, MA, USA
    BMC Psychiatry 7:43. 2007
    ..In this study, the safety and efficacy of duloxetine, a potent dual reuptake inhibitor of 5-HT and NE, were examined...
  3. ncbi Fluoxetine in the prevention of depressive recurrences: a double-blind study
    I Gilaberte
    Lilly Research Centre, Windlesham, Surrey, United Kingdom
    J Clin Psychopharmacol 21:417-24. 2001
    ..In conclusion, fluoxetine at 20 mg/day was effective and well tolerated for the prophylactic treatment of recurrent unipolar major depression...
  4. ncbi Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial
    J A Sacristan
    Clinical Research Department, Lilly SA, Madrid, Spain
    Int Clin Psychopharmacol 15:107-13. 2000
    ....
  5. ncbi Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study
    A Montoya
    Laboratorios Lilly, Spain
    Actas Esp Psiquiatr 35:315-22. 2007
    ..Although treatment for mania has been studied extensively in randomized clinical trials, there are few data that address how these patients are truly managed in clinical, functional, and economic terms in the psychiatric practice in Spain...